205 related articles for article (PubMed ID: 2113808)
21. The in vitro activity of gentamicin, tobramycin and netilmicin against 500 clinical isolates of bacteria. A comparative study using three different test media.
Digranes A; Dibb WL; Benonisen E; Ostervold B
Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):135-9. PubMed ID: 6408889
[TBL] [Abstract][Full Text] [Related]
22. Staphylococcal resistance to aminoglycosides before and after introduction of amikacin in two teaching hospitals.
Hammerberg O; Elder D; Richardson H; Landis S
J Clin Microbiol; 1986 Oct; 24(4):629-32. PubMed ID: 3771751
[TBL] [Abstract][Full Text] [Related]
23. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
Schassan HH
Infection; 1976; 4(2):35-41. PubMed ID: 789246
[TBL] [Abstract][Full Text] [Related]
24. Aminoglycoside resistance patterns in Turkey.
Akalin HE; Torun M; Alacam R
Scand J Infect Dis; 1988; 20(2):199-203. PubMed ID: 2840733
[TBL] [Abstract][Full Text] [Related]
25. In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.
Kabins SA; Nathan C; Cohen S
Antimicrob Agents Chemother; 1976 Jul; 10(1):139-45. PubMed ID: 825021
[TBL] [Abstract][Full Text] [Related]
26. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
Watanakunakorn C; Kauffman CA
Infection; 1978; 6(3):111-5. PubMed ID: 98451
[TBL] [Abstract][Full Text] [Related]
27. Reliability of a disk diffusion method using semiconfluent growth in the determination of aminoglycoside resistance.
Huovinen P; Herva E; Katila ML; Klossner ML; Renkonen OV; Toivanen P
Acta Pathol Microbiol Immunol Scand B; 1986 Jun; 94(3):153-7. PubMed ID: 3739715
[TBL] [Abstract][Full Text] [Related]
28. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae.
Briedis DJ; Robson HG
Antimicrob Agents Chemother; 1976 Oct; 10(4):592-7. PubMed ID: 825032
[TBL] [Abstract][Full Text] [Related]
29. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
[No Abstract] [Full Text] [Related]
30. In vitro study of netilmicin compared with other aminoglycosides.
Fu KP; Neu HC
Antimicrob Agents Chemother; 1976 Sep; 10(3):526-34. PubMed ID: 10829
[TBL] [Abstract][Full Text] [Related]
31. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
Knothe H
J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
[TBL] [Abstract][Full Text] [Related]
32. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
Husson MO; Izard D; Leclerc H
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
[TBL] [Abstract][Full Text] [Related]
33. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
Ruiz-Palacios GM; Ponce de Leon S; Sifuentes J; Ponce de Leon S; Calva JJ; Huazano F; Ontiveros C; Ojeda F; Bobadilla M
Am J Med; 1986 Jun; 80(6B):71-5. PubMed ID: 3089006
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
35. In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin.
Dhawan V; Marso E; Martin WJ; Young LS
Antimicrob Agents Chemother; 1977 Jan; 11(1):64-73. PubMed ID: 836015
[TBL] [Abstract][Full Text] [Related]
36. Development of gentamicin resistance in gram-negative bacteria in Czechoslovakia and correlation with its usage.
Kettner M; Krćméry V
Drugs Exp Clin Res; 1988; 14(8):511-7. PubMed ID: 2854783
[TBL] [Abstract][Full Text] [Related]
37. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.
Meyer RD; Draus LL; Pasieczinik KA
Antimicrob Agents Chemother; 1976 Oct; 10(4):677-81. PubMed ID: 825036
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of netilmicin, gentamicin, and amikacin.
Kantor RJ; Norden CW
Antimicrob Agents Chemother; 1977 Jan; 11(1):126-31. PubMed ID: 402104
[TBL] [Abstract][Full Text] [Related]
39.
Castanheira M; Davis AP; Mendes RE; Serio AW; Krause KM; Flamm RK
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866862
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme.
Schmitz FJ; Verhoef J; Fluit AC
Eur J Clin Microbiol Infect Dis; 1999 Jun; 18(6):414-21. PubMed ID: 10442419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]